Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03401749 · ClinicalTrials.gov registry record · Phase 4
Preadmission Skin Wipe Use for Surgical Site Infection Prophylaxis in Adult Orthopaedic Surgery Patients
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- Phase 4
- Development phase
- 203
- Enrollment target
NCT03401749 is a Phase 4 study that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 203 participants.
The verdict
NCT03401749, a Phase 4 study, was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 203 participants
- Enrollment target
Study Summary
Intervention: This study will involve three different study arms with different interventions prior to surgery: (1) shower only, (2) shower plus Theraworx wipes, (3) shower plus chlorhexidine wipes Study Design: Single center RCT Sample Size: 500 patients, aged 18+ Objectives: Primary Objectives: 1. Monitor for safety and adverse effects. 2. Evaluate for differences in peri-operative skin cultures between treatment groups; 3. Compare surgical site infection rates between groups. Secondary Objectives: 1. Assess for patient compliance for each different treatment arms. 2. Measure patient satisfaction. 3. Measure nurse satisfaction. 4. Visual assessment of wound healing Expected Results: We expect no statistically significant difference in peri-operative cultures or surgical site infection rates between groups.
Interventions
- DRUG Chlorhexidine Gluconate 2% Wipe
- OTHER Theraworx Bath Wipes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2020-12-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03401749
The ClinicalTrials.gov registry entry for NCT03401749 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Chlorhexidine Gluconate 2% Wipe is the first listed.
NCT03401749 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03401749 about?
NCT03401749 is a clinical study titled "Preadmission Skin Wipe Use for Surgical Site Infection Prophylaxis in Adult Orthopaedic Surgery Patients". Intervention: This study will involve three different study arms with different interventions prior to surgery: (1) shower only, (2) shower plus Theraworx wipes, (3) shower plus chlorhexidine wipes Study Design: Single center RCT Sample Size: 500 patients, aged 18+ Objectives: Primary Objectives:...
What is the current status of trial NCT03401749?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 203 participants. The study started on 2018-11-01. Estimated completion is 2020-12-01.
What interventions are being tested in trial NCT03401749?
The interventions under investigation include: Chlorhexidine Gluconate 2% Wipe (DRUG), Theraworx Bath Wipes (OTHER).
Who is sponsoring clinical trial NCT03401749?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.